Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/31/2023
MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
8/31/2023
Recent Official and Executive Moves
8/30/2023
Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
8/29/2023
NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
8/29/2023
Former Star Official of China's Healthcare Reform and VBP Architect ...
8/29/2023
Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...
8/28/2023
Regulation of Drug and Medical Device Advertising in China: An Industr...
8/28/2023
Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
8/25/2023
Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
8/25/2023
IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
8/25/2023
State Council Adopts New Action Plan for High-quality Development of P...
8/25/2023
China: The Latest Medtech Access Policies and Implications
8/24/2023
Review of China Performance of Leading MNCs in China H1/2023 (Updated)
8/24/2023
CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
8/23/2023
What China's New Patent Linkage and Patent Term Extension Systems Mean...
8/23/2023
Increasingly, State Investment and Middle Eastern Sovereign Wealth Are...
8/22/2023
Brand-Name Drugs Feel the Squeeze in China's Generic-Heavy Market (Pod...
8/22/2023
Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
8/21/2023
Moderna and CARsgen Join Forces to Combine mRNA Cancer Vaccine with CA...
8/18/2023
NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...
8/18/2023
Recent Executive Moves
8/17/2023
NMPA Revises the Information Standard System for Drug Regulatory Digit...
8/16/2023
Biocytogen Pharma Announces Opening of Waltham, MA Facility
8/16/2023
Chinese Drugmakers Develop Copycat Versions of 'Miracle' Weight-Loss D...
8/15/2023
Aurisco Pharma's Plant in Yangzhou Passes USFDA Inspection
8/14/2023
China Introduces New Policy to Boost Foreign Investment, Highlighting ...
8/14/2023
China's Medicine and Health Product Trade Down in H1/2023 as World Mov...
8/14/2023
China's Economy Is Showing Signs of Serious Trouble — And the Problem...
8/11/2023
China's Sitting on a Goldmine of Genetic Data – and It Doesn't Want t...
8/11/2023
Recent Executive Moves
Page:
41
/
355
Total number of articles:
10627
:
[First]
[<<]
[39]
[40]
[41]
[42]
[43]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit